The value of molecular monitoring for residual disease (MRD) in early morphological remitters among adults diagnosed with B cell ALL and treated according to the MRC UKALL12 protoc... by Foroni, L, Mitchell, W, Rai, L, Richards, S, Fielding, A, Goldstone, A

Sequential quantitative minimal residual disease in BCR-ABL positive acute lymphoblastic leukaemia: Differential observations between major and minor fusion gene rearrangements and... by Gerrard, G, Mitchell, W, Goldstone, A, Chopra, R, Buck, G, Richards, S, Foroni, L

The impact of imatinib therapy on adult Philadelphia positive acute lymphoblastic leukaemia (ALL): Early results from the UKALL12/ECOG 2993 study by Patel, B, Goldstone, A, Ross, P, Richards, S, Foroni, L, Chopra, R, Fielding, A

Clinical effect of Imatinib following remission induction in adult Philadelphia chromosome-positive acute lymphoblastic leukaemia: early results from the MRC UKALL12 Study by Patel, B, Goldstone, A, Ross, P, Foroni, L, Richards, S, Chopra, R, Fielding, A

Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell-origin of ALL subgroups - a UKALLXII study. by Rai, L, Casanova, A, Moorman, A, Richards, S, Buck, G, Goldstone, A, Fielding, A, Foroni, L

Value of molecular monitoring for minimal residual disease preceding autologous SCT following diagnosis of B cell acute lymphoblastic leukemia in patients treated with the MRC UKAL... by Foroni, L, Mitchell, W, Rai, L, Casanova, A, Patel, B, Richards, S, Fielding, A, Goldstone, A

Molecular monitoring of residual disease (MRD) during induction and intensification phases in low risk adult B cell ALL treated according to the MRC UKALL12 protocol. by Foroni, L, Mitchell, W, Rai, L, Casanova, A, Gerrard, G, Patel, B, Richards, S, Fielding, A, Goldstone, A

Minimal residual disease is a significant predictor of treatment failure in B lineage adult ALL: final results of the international trial UKALL XII:ECOG 2993 by Patel, B, Buck, G, Mortuza, Y, Rai, L, Mitchell, W, Gerrard, G, Hoffbrand, A, Goldstone, A, Foroni, L

10 YEARS EXPERIENCE OF TYROSINE KINASE INHIBITOR THERAPY FOR CML IN A SINGLE UK CENTRE: COMPARISON WITH PRE-TKI ERA AND EVALUATION OF 2013 ELN GUIDELINES by Khan, D, Roy, N, Bari, V, Vallance, G, Dreau, H, Littlewood, T, Peniket, A, Vyas, P, Foroni, L, Schuh, A, Mead, A

Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice. by Tse, E, Smith, A, Hunt, S, Lavenir, I, Forster, A, Warren, A, Grutz, G, Foroni, L, Carlton, M, Colledge, W, Boehm, T, Rabbitts, T

Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/EC... by Patel, B, Rai, L, Buck, G, Richards, S, Mortuza, Y, Mitchell, W, Gerrard, G, Moorman, A, Duke, V, Hoffbrand, A, Fielding, A, Goldstone, A, Foroni, L

Target enrichment and high-throughput sequencing of 80 ribosomal protein genes to identify mutations associated with Diamond-Blackfan anaemia by Gerrard, G, Valgañón, M, Foong, HE, Kasperaviciute, D, Iskander, D, Game, L, Müller, M, Aitman, TJ, Roberts, I, de la Fuente, J, Foroni, L, Karadimitris, A

Unlike Paediatric T-ALL, Notch-1 and FBXW7 Mutations Do Not Seem to Predict a Better Outcome in Adult Patients: Data from the UKALLXII/ECOG2993 Protocol. by Mansour, MR, Sulis, M, Duke, V, Foroni, L, Jenkinson, S, Allen, C, Gale, R, Buck, G, Richards, S, Paietta, E, Tallman, M, Goldstone, A, Rowe, J, Ferrando, A, Linch, D

Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol. by Mansour, MR, Sulis, M, Duke, V, Foroni, L, Jenkinson, S, Koo, K, Allen, C, Gale, R, Buck, G, Richards, S, Paietta, E, Rowe, J, Tallman, MS, Goldstone, A, Ferrando, A, Linch, D

UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia. by Fielding, A, Rowe, J, Buck, G, Foroni, L, Gerrard, G, Litzow, MR, Lazarus, H, Luger, S, Marks, D, McMillan, A, Moorman, A, Patel, B, Paietta, E, Tallman, MS, Goldstone, A

Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over... by Fielding, A, Rowe, J, Richards, S, Buck, G, Moorman, A, Durrant, I, Marks, D, McMillan, A, Litzow, MR, Lazarus, H, Foroni, L, Dewald, G, Franklin, I, Luger, S, Paietta, E, Wiernik, P, Tallman, MS, Goldstone, A

At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial by Ganzel, C, Wang, XV, Rowe, JM, Richards, SM, Buck, G, Marks, DI, Litzow, MR, Paietta, EM, Foroni, L, Luger, SM, Willman, CL, Mullighan, CG, Roberts, KG, Wiernik, PH, Douer, D, Lazarus, HM, Tallman, MS, Goldstone, AH

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia by Moorman, A, Harrison, C, Buck, G, Richards, S, Secker-Walker, L, Martineau, M, Vance, G, Cherry, A, Higgins, R, Fielding, A, Foroni, L, Paietta, E, Tallman, MS, Wernik, P, Litzow, MR, Rowe, J, Goldstone, A, Dewald, G

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC)... by Moorman, A, Harrison, C, Buck, G, Richards, S, Secker-Walker, L, Martineau, M, Vance, G, Cherry, A, Higgins, R, Fielding, A, Foroni, L, Paietta, E, Tallman, MS, Litzow, MR, Wiernik, P, Rowe, J, Goldstone, A, Dewald, G

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia by Moorman, A, Harrison, C, Buck, G, Richards, S, Secker-Walker, L, Martineau, M, Vance, G, Cherry, A, Higgins, R, Fielding, A, Foroni, L, Paietta, E, Tallman, MS, Litzow, MR, Wiernik, P, Rowe, J, Goldstone, A, Dewald, G